Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDEN: Glucose-Sparing PD Solutions in Diabetic CAPD
NCT01219959Phase 3Completed
- Sponsor
- Vanttive
- Start
- Oct 2010
- Primary completion
- Jul 2011
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of icodextrin, Nutrineal in end stage renal disease (ESRD), sponsored by Vanttive. Started Oct 2010; status: completed.
02
Drugs
icodextrinNutrineal
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01219959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01219959.